HT
RETA

Headlands Technologies’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Headlands Technologies’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,602
Closed -$265K – 1273
2023
Q2 		$265K Buy
+2,602
New +$265K 0.08% 243